Added to YB: 2025-07-18
Pitch date: 2025-07-17
IKNA [bullish]
Ikena Oncology, Inc.
Author Info
BiotechBonanza shares takes on biotech with a heavy focus on special situations. Sign up for the newsletter.
Company Info
Ikena Oncology, Inc., an oncology company, focuses on developing therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance.
Market Cap
$68.5M
Pitch Price
N/A
Price Target
2.38
Dividend
N/A
Sector
Pharmaceuticals
Category
special_situation
IKNA: A very... special... situation
IKNA: Rare setup w/ stock trading 45% below PIPE w/ T1 investors. Merger recently approved despite 45% opposition. CVR rights to former assets, including potential $500M from Pionyr (50% of $1B deal). OX40 mAb drug for AD showing early promise. Risk: 17M 'no' shares (35%) may sell after close. Entry <$1.43 (60% of deal price).
Read full article (8 min)